Business
Wellbeing Digital Subsidiary KGK to Participate in the Supply Side West Conference
Wellbeing Digital Subsidiary KGK to Participate in the Supply Side West Conference.
About this update from Wellbeing Digital Sciences Inc.
[{"type":"text","content":"\nWellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that Erin Lewis, Scientific Director of KGK Sciences Inc. (“KGK”), the Company’s wholly owned subsidiary, will participate at the Supply Side West Conference taking place on October 31st to November 4, 2022 in Las Vegas, NV.\n\nErin Lewis will participate on the “Exploring the Microbiome: Science, Innovation and Delivery” panel on November 1st at 1pm.\n\nThis session will cover:\n\n\nAn exploration of the volume and nature of evidence to support health benefits\n\n\nPerspectives from the registered dietician and health care practitioner sector about how to best reach end-consumers with microbiome solutions\n\n\nMarket data insights on consumer buying and delivery formats\n\n\nInnovators on the technological front lines who aim to biohack the multitude of human microbial communities and influence their impact on health and performance\n\n\nRegister to attend here.\n\nFor more information about the conference, or to schedule a one-on-one meeting with Wellbeing or KGK’s management team, please send an email to Natalie Dolphin at [email protected].\n\nABOUT KGK SCIENCE\n\nSubsidiary of Wellbeing Digital Sciences, KGK is a leading North American contract research organization based in London, Ontario that primarily provides high-quality clinical research trials with a focus on nutraceutical and emerging health care products. Founded in 1997, the business has successfully helped hundreds of companies with custom designed clinical trials and claim substantiation strategies to move products into global markets. KGK’s other existing service lines include expert regulatory support and compliance solutions, participant recruitment, research support services and consulting services. Furthermore, the company has produced over 150 publications, executed over 400 clinical trials across more than 40 indications, amassed 25,000 participants in its database and collected 10 million data points. For additional information, please visit kgkscience.com....